ロード中...
The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF
PURPOSE: To report the incidence and associated factors for the development of vitreomacular interface abnormality (VMIA) in patients with diabetic macular edema (DME) who received intravitreal injection (IVI) of anti-VEGF (Bevacizumab and Ranibizumab) treatment. METHODS: A retrospective observation...
保存先:
| 出版年: | Eye (Lond) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437328/ https://ncbi.nlm.nih.gov/pubmed/28106889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2016.317 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|